MiR-613 Suppresses Retinoblastoma Cell Proliferation, Invasion, and Tumor Formation by Targeting E2F5
Overview
Affiliations
Retinoblastoma is a common intraocular malignancy that occurs during childhood. MicroRNAs play critical roles in the regulation of retinoblastoma initiation and progression, and aberrant expression of miR-613 had been reported in various types of cancer. However, the role and mechanism of its function in retinoblastoma are still unclear. In this study, we found that miR-613 was downregulated in retinoblastoma tissues and cell lines. Overexpression of miR-613 suppressed retinoblastoma cell proliferation, migration, and invasion and induced cell cycle arrest in vitro. Additionally, overexpressed miR-613 also inhibited tumor formation of retinoblastoma cells in vivo. We further identified E2F5 as a direct target of miR-613. Reintroduction of E2F5 without 3'-untranslated region reversed the inhibitory effects of miR-613 on cell proliferation and invasion. Our data collectively indicate that miR-613 functions as a tumor suppressor in retinoblastoma through downregulating E2F5, supporting the targeting of the novel miR-613/E2F5 axis as a potentially effective therapeutic approach for retinoblastoma.
Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.
Ahangar Davoodi N, Najafi S, Ghale-Noie Z, Piranviseh A, Mollazadeh S, Ahmadi Asouri S Front Cell Dev Biol. 2023; 10:1065837.
PMID: 36619866 PMC: 9816416. DOI: 10.3389/fcell.2022.1065837.
Deng L, Yin Q, Liu S, Luo D Dis Markers. 2022; 2022:5699275.
PMID: 36061358 PMC: 9439912. DOI: 10.1155/2022/5699275.
Jiang G, Qu M, Kong L, Song X, Jiang S Biomed Res Int. 2022; 2022:6918396.
PMID: 35909488 PMC: 9325647. DOI: 10.1155/2022/6918396.
MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN.
Gao M, Cui Z, Zhao D, Zhang S, Cai Q Genes Genomics. 2021; 43(9):1023-1033.
PMID: 34129195 DOI: 10.1007/s13258-021-01043-w.
A Novel Circular RNA circCSPP1 Promotes Liver Cancer Progression by Sponging miR-1182.
Jia N, Song Z, Chen B, Cheng J, Zhou W Onco Targets Ther. 2021; 14:2829-2838.
PMID: 33935503 PMC: 8079351. DOI: 10.2147/OTT.S292320.